Sodium iodide I 131
(FVAUCKIRQBBSSJ-LAIFMVDKSA-M)
Structure
- SMILES
- [Na+].[131I-]
- Molecular Formula:
- INa
- Molecular Weight:
- 153.896
- Log P:
- -2.9960
- Hydrogen Bond Acceptor:
- 0
- Hydrogen Bond Donor:
- 0
- TPSA:
- 0
- CAS Number(s):
- 7790-26-3; 65542-51-0
Synonym(s)
1.
Sodium iodide I 131
External Link(s)
| PubChem Compound | 71368 |
| CHEMBL | CHEMBL1201084 |
| KEGG | dr:D02259 |
| Therapeutic Target Database | D0O6OZ |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hypothyroidism | FAERS: 276 | US FAERS | |
| 2 | MYELODYSPLASTIC SYNDROME | FAERS: 22 | US FAERS | |
| 3 | Hyperparathyroidism | FAERS: 21 | US FAERS | |
| 4 | treatment failure | FAERS: 20 | US FAERS | |
| 5 | Hyperthyroidism | FAERS: 11 | US FAERS | |
| 6 | Pulmonary Fibrosis | FAERS: 10 | US FAERS | |
| 7 | Nausea | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Vomiting | FAERS: 8 | US FAERS | |
| 9 | Dacryostenosis acquired | FAERS: 7 | US FAERS | |
| 10 | Drug exposure during pregnancy | FAERS: 7 | US FAERS | |
| 11 | Radiation Pneumonitis | FAERS: 7 | US FAERS | |
| 12 | Congenital Hypothyroidism | FAERS: 6 | US FAERS | |
| 13 | Drug exposure before pregnancy | FAERS: 5 | US FAERS | |
| 14 | Autoimmune thyroiditis | FAERS: 4 | US FAERS | |
| 15 | Stillbirth | FAERS: 4 | US FAERS | |
| 16 | Cyanosis | FAERS: 3 | US FAERS | |
| 17 | Fatigue | FAERS: 3 | US FAERS | |
| 18 | Hypoparathyroidism | FAERS: 3 | US FAERS | |
| 19 | Musculoskeletal discomfort | FAERS: 3 | US FAERS | |
| 20 | Parotitis | FAERS: 3 | US FAERS | |
| 21 | Pruritus | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 22 | Rash erythematous | FAERS: 3 | US FAERS | |
| 23 | Refractory cytopenia with multilineage dysplasia | FAERS: 3 | US FAERS | |
| 24 | Respiratory Failure | FAERS: 3 | US FAERS | |
| 25 | Thyroid Neoplasm | FAERS: 3 | US FAERS | |
| 26 | Vocal Cord Paralysis | FAERS: 3 | US FAERS | |
| 27 | Ageusia | FAERS: 2 | US FAERS | |
| 28 | Apallic syndrome | FAERS: 2 | US FAERS | |
| 29 | Arthralgia | FAERS: 2 | US FAERS | |
| 30 | Astrocytoma | FAERS: 2 | US FAERS | |
| 31 | Blood thyroid stimulating hormone increased | FAERS: 2 | US FAERS | |
| 32 | Brain stem syndrome | FAERS: 2 | US FAERS | |
| 33 | Disease Progression | FAERS: 2 | US FAERS | |
| 34 | Exophthalmos | FAERS: 2 | US FAERS | |
| 35 | Hydrocephalus | FAERS: 2 | US FAERS | |
| 36 | Hypersensitivity | FAERS: 2 | US FAERS | |
| 37 | Lung infection pseudomonal | FAERS: 2 | US FAERS | |
| 38 | Maternal exposure during pregnancy | FAERS: 2 | US FAERS | |
| 39 | Neck Pain | FAERS: 2 | US FAERS | |
| 40 | Neonatal thyrotoxicosis | FAERS: 2 | US FAERS | |
| 41 | Pain | FAERS: 2 | US FAERS | |
| 42 | Pancytopenia | FAERS: 2 | US FAERS | |
| 43 | Pneumonia | FAERS: 2 | US FAERS | |
| 44 | Radiation exposure during pregnancy | FAERS: 2 | US FAERS | |
| 45 | Sepsis | FAERS: 2 | US FAERS | |
| 46 | Thyroid dermatopathy | FAERS: 2 | US FAERS | |
| 47 | Thyrotoxic periodic paralysis | FAERS: 2 | US FAERS | |
| 48 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 49 | Acute psychosis | FAERS: 1 | US FAERS | |
| 50 | Apathy | FAERS: 1 | US FAERS | |
| 51 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 52 | Basal cell carcinoma | FAERS: 1 | US FAERS | |
| 53 | Biopsy thyroid gland abnormal | FAERS: 1 | US FAERS | |
| 54 | Bone Sarcoma | FAERS: 1 | US FAERS | |
| 55 | Bradycardia | FAERS: 1 | US FAERS | |
| 56 | Bronchiectasis | FAERS: 1 | US FAERS | |
| 57 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 58 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 59 | Dizziness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 60 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 61 | Dysphonia | FAERS: 1 | US FAERS | |
| 62 | Dystrophic calcification | FAERS: 1 | US FAERS | |
| 63 | Dysuria | FAERS: 1 | US FAERS | |
| 64 | Ecchymosis | FAERS: 1 | US FAERS | |
| 65 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 66 | Eosinophilia | FAERS: 1 | US FAERS | |
| 67 | Erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Exposure to radiation | FAERS: 1 | US FAERS | |
| 69 | Facial Pain | FAERS: 1 | US FAERS | |
| 70 | False positive investigation result | FAERS: 1 | US FAERS | |
| 71 | Febrile Neutropenia | FAERS: 1 | US FAERS | |
| 72 | Feeding tube complication | FAERS: 1 | US FAERS | |
| 73 | Fracture | FAERS: 1 | US FAERS | |
| 74 | Headache | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 75 | Hemiparesis | FAERS: 1 | US FAERS | |
| 76 | Hypotension | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 77 | Hypoventilation | FAERS: 1 | US FAERS | |
| 78 | Hypoxia | FAERS: 1 | US FAERS | |
| 79 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 80 | Infection | FAERS: 1 | US FAERS | |
| 81 | Lagophthalmos | FAERS: 1 | US FAERS | |
| 82 | Leukopenia | FAERS: 1 | US FAERS | |
| 83 | Lung Injury | FAERS: 1 | US FAERS | |
| 84 | Macrocephaly | FAERS: 1 | US FAERS | |
| 85 | Malignant neoplasm progression | FAERS: 1 | US FAERS | |
| 86 | Maternal exposure before pregnancy | FAERS: 1 | US FAERS | |
| 87 | Mental status changes | FAERS: 1 | US FAERS | |
| 88 | Metabolic acidosis | FAERS: 1 | US FAERS | |
| 89 | Metabolic alkalosis | FAERS: 1 | US FAERS | |
| 90 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 91 | Ovarian failure | FAERS: 1 | US FAERS | |
| 92 | Pancreatitis | FAERS: 1 | US FAERS | |
| 93 | Pericardial effusion | FAERS: 1 | US FAERS | |
| 94 | Peritoneal cyst | FAERS: 1 | US FAERS | |
| 95 | Placental Insufficiency | FAERS: 1 | US FAERS | |
| 96 | Pre-Eclampsia | FAERS: 1 | US FAERS | |
| 97 | Product container issue | FAERS: 1 | US FAERS | |
| 98 | Product physical issue | FAERS: 1 | US FAERS | |
| 99 | Pulmonary radiation injury | FAERS: 1 | US FAERS | |
| 100 | Radiation Fibrosis | FAERS: 1 | US FAERS | |
| 101 | Radiation larynx injury | FAERS: 1 | US FAERS | |
| 102 | Radiation thyroiditis | FAERS: 1 | US FAERS | |
| 103 | Renal Artery Stenosis | FAERS: 1 | US FAERS | |
| 104 | Renal Cell Carcinoma | FAERS: 1 | US FAERS | |
| 105 | Restrictive pulmonary disease | FAERS: 1 | US FAERS | |
| 106 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 107 | Salivary gland adenoma | FAERS: 1 | US FAERS | |
| 108 | Secondary hypothyroidism | FAERS: 1 | US FAERS | |
| 109 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 110 | Spinal column stenosis | FAERS: 1 | US FAERS | |
| 111 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 112 | Stridor | FAERS: 1 | US FAERS | |
| 113 | Swelling | FAERS: 1 | US FAERS | |
| 114 | Tetany | FAERS: 1 | US FAERS | |
| 115 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 116 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 117 | Thyroid atrophy | FAERS: 1 | US FAERS | |
| 118 | Thyroid calcification | FAERS: 1 | US FAERS | |
| 119 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 120 | Transient psychosis | FAERS: 1 | US FAERS | |
| 121 | Trisomy 21 | FAERS: 1 | US FAERS | |
| 122 | Tumour haemorrhage | FAERS: 1 | US FAERS | |
| 123 | Urticaria | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 124 | Weight decreased | FAERS: 1 | US FAERS | |
| 125 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 126 | synovial sarcoma | FAERS: 1 | US FAERS | |
| 127 | Disorientation | Canada Vigilance: 1 | Canada Vigilance | |
| 128 | Dysgeusia | Canada Vigilance: 1 | Canada Vigilance | |
| 129 | Flushing | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.